Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC-Reference-Cited by-同舟云学术

Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC

Published:2024-08-15 Issue:7 Volume:391 Page:585-597
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Lu Shun¹,Kato Terufumi¹,Dong Xiaorong¹,Ahn Myung-Ju¹,Quang Le-Van¹,Soparattanapaisarn Nopadol¹,Inoue Takako¹,Wang Chih-Liang¹,Huang Meijuan¹,Yang James Chih-Hsin¹,Cobo Manuel¹,Özgüroğlu Mustafa¹,Casarini Ignacio¹,Khiem Dang-Van¹,Sriuranpong Virote¹,Cronemberger Eduardo¹,Takahashi Toshiaki¹,Runglodvatana Yotsawaj¹,Chen Ming¹,Huang Xiangning¹,Grainger Ellie¹,Ghiorghiu Dana¹,van der Gronde Toon¹,Ramalingam Suresh S.¹

Affiliation:

1. From the Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai (S.L.), the Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan (X.D.), the Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu (M.H.), the Department of Radiotherapy, the Cancer Hospital of the University of Chinese...

Funder

AstraZeneca

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2402614

Reference40 articles.

1. Royal College of Physicians. NLCA annual report. 2018 (https://www.hqip.org.uk/resource/national-lung-cancer-audit-annual-report-2018).

2. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007

3. Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment

4. Retrospective Cohort Study of Unresectable Stage III Non-Small-Cell Lung Cancer in Canada

5. Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. On the Need for Better Information from Randomized Clinical Trials in Oncology;2024-09-03

3. PROshot: Immunotherapy for Cervical Cancer, Epidermal Growth Factor Receptor-Mutated Stage III Lung Cancer, Perioperative Chemotherapy for Esophageal Cancer, Salvage Postprostatectomy Radiation and Androgen Deprivation Therapy, and Immunotherapy for Head and Neck Cancer;Practical Radiation Oncology;2024-09

4. Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario;Current Oncology;2024-08-30

5. Osimertinib-Induced Myositis in a Patient With Metastatic Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation;Cureus;2024-08-23